• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐药性颞叶癫痫成人患者的淀粉样蛋白沉积

Amyloid deposition in adults with drug-resistant temporal lobe epilepsy.

作者信息

Fonseca Elena, Lallana Sofía, Ortega Gemma, Cano Amanda, Sarria-Estrada Silvana, Pareto Deborah, Quintana Manuel, Lorenzo-Bosquet Carles, López-Maza Samuel, Gifreu Ariadna, Campos-Fernández Daniel, Abraira Laura, Santamarina Estevo, Orellana Adelina, Montrreal Laura, Puerta Raquel, Aguilera Núria, Ramis Maribel, de Rojas Itziar, Ruiz Agustín, Tárraga Lluis, Rovira Àlex, Marquié Marta, Boada Mercè, Toledo Manuel

机构信息

Epilepsy Unit, Neurology Department, Medicine Department, Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Research Group on Status Epilepticus and Acute Seizures, Vall d'Hebron Research Institute, Vall d'Hebron University Hospital, Vall d'Hebron Hospital Campus, Barcelona, Spain.

出版信息

Epilepsia. 2024 Dec;65(12):3664-3675. doi: 10.1111/epi.18142. Epub 2024 Oct 15.

DOI:10.1111/epi.18142
PMID:39403981
Abstract

OBJECTIVE

Pathological amyloid-β (Aβ) accumulation and hyperphosphorylated tau proteins have been described in resected temporal lobe specimens of epilepsy patients. We aimed to determine cerebrospinal fluid (CSF) Aβ1-42 and p181-tau levels and cerebral Aβ deposits on positron emission tomography (Aβ PET) and correlate these findings with cognitive performance in adults with drug-resistant temporal lobe epilepsy (TLE).

METHODS

In this cross-sectional study, we enrolled individuals with drug-resistant TLE who were 25-55 years old. Each participant underwent F-flutemetamol PET, determination of CSF Aβ1-42, p181-tau, and total tau, and a comprehensive neuropsychological assessment. We evaluated normalized standard uptake value ratios (SUVRs) for different brain regions on Aβ PET.

RESULTS

Thirty patients (mean age = 41.9 ± SD 8.1 years, 57% men) were included. The median disease duration was 9.5 (interquartile range = 4-24) years. Twenty-six patients (87%) had a clinically significant cognitive impairment on neuropsychological evaluation, 18 (69%) of the amnesic type. On Aβ PET, high uptake was observed in both mesial temporal regions (ipsilateral: SUVR z-score = .90, 95% confidence interval [CI] = .60-1.20; contralateral: SUVR z-score = .92, 95% CI = .57-1.27; p < .001), which was higher when compared to SUVR z-scores in all the remaining regions (p < .001) and in the ipsilateral anterior cingulate (SUVR z-score = .27, 95% CI = .04-.49, p = .020). No significant deposition was observed in other regions. Seven patients (23%) had low Aβ1-42 levels, and two (7%) had elevated p181-tau levels in CSF. Higher p181-tau levels correlated with poorer verbal fluency (R = -.427, p = .044).

SIGNIFICANCE

Our findings reveal a considerable Aβ deposition in mesial temporal regions and ipsilateral anterior cingulate among adults with drug-resistant TLE. Additionally, abnormal CSF Aβ1-42 levels were observed in a significant proportion of patients, and p181-tau levels were associated with verbal fluency. These results suggest that markers of neuronal damage can be observed in adults with TLE, warranting further investigation.

摘要

目的

在癫痫患者切除的颞叶标本中已发现病理性淀粉样β蛋白(Aβ)积聚和tau蛋白高度磷酸化。我们旨在测定耐药物性颞叶癫痫(TLE)成人患者的脑脊液(CSF)Aβ1-42和p181-tau水平以及正电子发射断层扫描(Aβ PET)上的脑Aβ沉积情况,并将这些结果与认知表现相关联。

方法

在这项横断面研究中,我们纳入了年龄在25至55岁之间的耐药物性TLE患者。每位参与者均接受了F-氟代甲磺酸美他莫尔PET检查、脑脊液Aβ1-42、p181-tau和总tau的测定,以及全面的神经心理学评估。我们评估了Aβ PET上不同脑区的标准化标准摄取值比率(SUVRs)。

结果

共纳入30例患者(平均年龄 = 41.9 ±标准差8.1岁,57%为男性)。疾病中位持续时间为9.5年(四分位间距 = 4 - 24年)。26例患者(87%)在神经心理学评估中存在具有临床意义的认知障碍,其中18例(69%)为遗忘型。在Aβ PET上,双侧内侧颞叶区域均观察到高摄取(同侧:SUVR z评分 =.90,95%置信区间[CI] =.60 - 1.20;对侧:SUVR z评分 =.92,95% CI =.57 - 1.27;p <.001),与所有其他区域的SUVR z评分相比更高(p <.001),且高于同侧前扣带回(SUVR z评分 =.27,95% CI =.04 -.49,p =.020)。在其他区域未观察到明显沉积。7例患者(23%)脑脊液Aβ1-42水平较低,2例(7%)脑脊液p181-tau水平升高。p181-tau水平越高,言语流畅性越差(R = -.427,p =.044)。

意义

我们的研究结果揭示了耐药物性TLE成人患者双侧内侧颞叶区域和同侧前扣带回中存在大量Aβ沉积。此外,相当比例的患者脑脊液Aβ1-42水平异常,且p181-tau水平与言语流畅性相关。这些结果表明,在TLE成人患者中可观察到神经元损伤标志物,值得进一步研究。

相似文献

1
Amyloid deposition in adults with drug-resistant temporal lobe epilepsy.耐药性颞叶癫痫成人患者的淀粉样蛋白沉积
Epilepsia. 2024 Dec;65(12):3664-3675. doi: 10.1111/epi.18142. Epub 2024 Oct 15.
2
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
3
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
4
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta.载脂蛋白E4(APOE4)对可溶性和不溶性tau蛋白病理的影响主要受β-淀粉样蛋白的影响。
Brain. 2025 Jan 16. doi: 10.1093/brain/awaf016.
5
Associations Between Self and Study Partner Report of Cognitive Decline With Regional Tau in a Multicohort Study.多队列研究中自我和学习伙伴报告的认知能力下降与区域 tau 之间的关联。
Neurology. 2024 Jun 25;102(12):e209447. doi: 10.1212/WNL.0000000000209447. Epub 2024 May 29.
6
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study.淀粉样蛋白 PET 和 tau-PET 评估唐氏综合征患者症状性阿尔茨海默病的时间轴:一项纵向队列研究。
Lancet Neurol. 2024 Dec;23(12):1214-1224. doi: 10.1016/S1474-4422(24)00426-5.
7
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's Continuum.血浆p217 + tau在阿尔茨海默病连续体中的两年预后效用
J Prev Alzheimers Dis. 2023;10(4):828-836. doi: 10.14283/jpad.2023.83.
8
Predicting Driving Cessation Among Cognitively Normal Older Drivers: The Role of Alzheimer Disease Biomarkers and Clinical Assessments.预测认知正常的老年驾驶员停止驾驶的情况:阿尔茨海默病生物标志物和临床评估的作用。
Neurology. 2024 Jun 25;102(12):e209426. doi: 10.1212/WNL.0000000000209426. Epub 2024 Apr 15.
9
Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum.阿尔茨海默病临床谱系中脑脊液淀粉样蛋白和 Tau 生物标志物的变化
JAMA Netw Open. 2025 Jul 1;8(7):e2519919. doi: 10.1001/jamanetworkopen.2025.19919.
10
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study.利用血浆生物标志物预测唐氏综合征患者的淀粉样蛋白和tau蛋白脑沉积及认知衰退:一项纵向队列研究。
Lancet Neurol. 2025 Jul;24(7):591-600. doi: 10.1016/S1474-4422(25)00158-9.

引用本文的文献

1
Epilepsy and Amyloid: The Plot Thickens… So Will the Brain Thin?癫痫与淀粉样蛋白:情节愈发复杂……大脑也会随之萎缩吗?
Epilepsy Curr. 2025 Apr 16:15357597251333160. doi: 10.1177/15357597251333160.